Manufacturer of Controlled Substances; Notice of Registration, 31539 [05-10787]

Download as PDF Federal Register / Vol. 70, No. 104 / Wednesday, June 1, 2005 / Notices in the Subject Country accounted for by your firm’s(s’) production; and (b) The quantity and value of your firm’s(s’) exports to the United States of Subject Merchandise and, if known, an estimate of the percentage of total exports to the United States of Subject Merchandise from the Subject Country accounted for by your firm’s(s’) exports. (10) Identify significant changes, if any, in the supply and demand conditions or business cycle for the Domestic Like Product that have occurred in the United States or in the market for the Subject Merchandise in the Subject Country after 1999, and significant changes, if any, that are likely to occur within a reasonably foreseeable time. Supply conditions to consider include technology; production methods; development efforts; ability to increase production (including the shift of production facilities used for other products and the use, cost, or availability of major inputs into production); and factors related to the ability to shift supply among different national markets (including barriers to importation in foreign markets or changes in market demand abroad). Demand conditions to consider include end uses and applications; the existence and availability of substitute products; and the level of competition among the Domestic Like Product produced in the United States, Subject Merchandise produced in the Subject Country, and such merchandise from other countries. (11) (Optional) A statement of whether you agree with the above definitions of the Domestic Like Product and Domestic Industry; if you disagree with either or both of these definitions, please explain why and provide alternative definitions. Authority: This review is being conducted under authority of title VII of the Tariff Act of 1930; this notice is published pursuant to section 207.61 of the Commission’s rules. By order of the Commission. Issued: May 23, 2005. Marilyn R. Abbott, Secretary to the Commission. [FR Doc. 05–10883 Filed 5–31–05; 8:45 am] BILLING CODE 7020–02–P DEPARTMENT OF JUSTICE Drug Enforcement Administration Manufacturer of Controlled Substances; Notice of Registration By Notice dated February 9, 2005, and published in the Federal Register on February 15, 2005, (70 FR 7760), VerDate jul<14>2003 16:22 May 30, 2005 Jkt 205001 31539 Clariant LSM (Missouri) Inc., 2460 W. Bennett Street, Springfield, Missouri 65807–1229, (Mailing Address: P.O. Box 1246, Springfield, Missouri 65801) made application to the Drug Enforcement Administration (DEA) to be registered as a bulk manufacturer of Methylphenidate (1724), a basic class of controlled substance listed in Schedule II. The company plans to manufacture the listed controlled substance in bulk for research purposes. No comments or objections have been received. DEA has considered the factors in 21 U.S.C. 823(a) and determined that the registration of Clariant LSM (Missouri) Inc. to manufacture the listed basic class of controlled substance is consistent with the public interest at this time. DEA has investigated Clariant LSM (Missouri) Inc. to ensure that the company’s registration is consistent with the public interest. The investigation has included inspection and testing of the company’s physical security systems, verification of the company’s compliance with state and local laws, and a review of the company’s background and history. Therefore, pursuant to 21 U.S.C. 823, and in accordance with 21 CFR 1301.33, the above named company is granted registration as a bulk manufacturer of the basic class of controlled substance listed. AGENCY CONTACT: Thomas W. Hutchison, Chief of Staff, United States Parole Commission, (301) 492–5990. Dated: May 25, 2005. William J. Walker, Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration. [FR Doc. 05–10787 Filed 5–31–05; 8:45 am] Dated: May 26, 2005. Rockne Chickinell, General Counsel, U.S. Parole Commission. [FR Doc. 05–10944 Filed 5–27–05; 10:40 am] Dated: May 26, 2005. Rockne Chickinell, General Counsel. [FR Doc. 05–10943 Filed 5–27–05; 10:40 am] BILLING CODE 4410–31–M DEPARTMENT OF JUSTICE Parole Commission Public Announcement Pursuant to the Government in the Sunshine Act (Pub. L. 94–409) (5 U.S.C. 552b) 9:30 a.m., Thursday, June 2, 2005. PLACE: 5550 Friendship Blvd., Fourth Floor, Chevy Chase, MD 20815. STATUS: Open. MATTERS TO BE CONSIDERED: The following matters have been placed on the agenda for the open Parole Commission meeting: 1. Approval of Minutes of Previous Commission Meeting. 2. Reports from the Chairman, Commissioners, Legal, Chief of Staff, Case Operations, and Administrative Sections. AGENCY CONTACT: Thomas W. Hutchison, Chief of Staff, United States Parole Commission, (301) 492–5990. TIME AND DATE: BILLING CODE 4410–31–M BILLING CODE 4410–09–P DEPARTMENT OF LABOR Employment and Training Administration DEPARTMENT OF JUSTICE Parole Commission Public Announcement Pursuant to the Government in the Sunshine Act (Pub. L. 94–409) (5 U.S.C. 552b) 10:30 a.m., Thursday, June 2, 2005. PLACE: U.S. Parole Commission, 5550 Friendship Boulevard, 4th Floor, Chevy Chase, Maryland 20815. STATUS: Closed—Meeting. MATTERS TO BE CONSIDERED: The following matter will be considered during the closed portion of the Commission’s Business Meeting: Case deliberations or review of two original jurisdiction cases conducted pursuant to 28 CFR Sec. 2.17 and 28 CFR Sec. 2.27. DATE AND TIME: PO 00000 Frm 00129 Fmt 4703 Sfmt 4703 Solicitation for Grant Applications (SGA); Prisoner Re-Entry Initiative Employment and Training Administration (ETA), Labor. ACTION: Notice; additional information and correction. AGENCY: SUMMARY: The Employment and Training Administration published a document in the Federal Register on April 1, 2005, concerning the availability of grant funds for eligible faith-based and community organizations under the Prisoner ReEntry Initiative: SGA/DFA PY–04–08. This is to make the following clarifications and corrections to SGA/ DFA PY–04–08: 1. The SGA intended that Workforce Investment Boards (WIBs) would have a E:\FR\FM\01JNN1.SGM 01JNN1

Agencies

[Federal Register Volume 70, Number 104 (Wednesday, June 1, 2005)]
[Notices]
[Page 31539]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 05-10787]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Manufacturer of Controlled Substances; Notice of Registration

    By Notice dated February 9, 2005, and published in the Federal 
Register on February 15, 2005, (70 FR 7760), Clariant LSM (Missouri) 
Inc., 2460 W. Bennett Street, Springfield, Missouri 65807-1229, 
(Mailing Address: P.O. Box 1246, Springfield, Missouri 65801) made 
application to the Drug Enforcement Administration (DEA) to be 
registered as a bulk manufacturer of Methylphenidate (1724), a basic 
class of controlled substance listed in Schedule II.
    The company plans to manufacture the listed controlled substance in 
bulk for research purposes.
    No comments or objections have been received. DEA has considered 
the factors in 21 U.S.C. 823(a) and determined that the registration of 
Clariant LSM (Missouri) Inc. to manufacture the listed basic class of 
controlled substance is consistent with the public interest at this 
time. DEA has investigated Clariant LSM (Missouri) Inc. to ensure that 
the company's registration is consistent with the public interest. The 
investigation has included inspection and testing of the company's 
physical security systems, verification of the company's compliance 
with state and local laws, and a review of the company's background and 
history. Therefore, pursuant to 21 U.S.C. 823, and in accordance with 
21 CFR 1301.33, the above named company is granted registration as a 
bulk manufacturer of the basic class of controlled substance listed.

    Dated: May 25, 2005.
William J. Walker,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. 05-10787 Filed 5-31-05; 8:45 am]
BILLING CODE 4410-09-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.